We are live on ! Find out more
TAM

Tiverton Asset Management Portfolio holdings

AUM $2.88B
1-Year Est. Return 5.6%
This Fund
S&P 500
This Quarter Est. Return
+0.87%
1 Year Est. Return
+5.6%
3 Year Est. Return
+61.69%
5 Year Est. Return
+105.13%
10 Year Est. Return
AUM
$2.38B
AUM Growth
-$561M
Cap. Flow
+$1.18B
Cap. Flow %
49.67%
Top 10 Hldgs %
26.67%
Holding
159
New
Increased
66
Reduced
87
Closed
6

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$1.17B
2
AMZN icon
Amazon
AMZN
+$217M
3
ICE icon
Intercontinental Exchange
ICE
+$202M
4
FDS icon
Factset
FDS
+$99.5M
5
AMT icon
American Tower
AMT
+$70.6M

Sector Composition

Rank Sector Weight
1 Healthcare 21.43%
2 Technology 17.45%
3 Financials 11.94%
4 Industrials 11.04%
5 Consumer Discretionary 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDVN
126
DELISTED
MEDIVATION, INC.
MDVN
$2.83M 0.12%
114,726
-176
-0.2% -$9.98K
PB icon
127
Prosperity Bancshares
PB
$8.98B
$2.75M 0.12%
92,217
-252,242
-73% -$12.7M
MPWR icon
128
Monolithic Power Systems
MPWR
$65.6B
$2.63M 0.11%
233,709
+216,130
+1,229% +$14.2M
HQY icon
129
HealthEquity
HQY
$8.78B
$2.59M 0.11%
22,945
-16,055
-41% -$422K
BDSI
130
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$2.55M 0.11%
58,949
-439,814
-88% -$1.21M
MDSO
131
DELISTED
Medidata Solutions, Inc.
MDSO
$2.45M 0.1%
35,888
-25,623
-42% -$1.12M
AMBR
132
DELISTED
Amber Road Inc
AMBR
$2.32M 0.1%
43,863
-478,282
-92% -$2.79M
LFUS icon
133
Littelfuse
LFUS
$11.8B
$2.24M 0.09%
47,803
-47,130
-50% -$5.48M
SRCL
134
DELISTED
Stericycle Inc
SRCL
$2.19M 0.09%
222,750
-133,830
-38% -$14.3M
KRE icon
135
State Street SPDR S&P Regional Banking ETF
KRE
$4.74B
$1.85M 0.08%
336,374
+171,825
+104% +$6.79M
PX
136
DELISTED
Praxair Inc
PX
$1.77M 0.07%
220,469
+64,202
+41% +$7.28M
HSIC icon
137
Henry Schein
HSIC
$10.2B
$1.39M 0.06%
86,641
-467,528
-84% -$31.6M
CME icon
138
CME Group
CME
$94.4B
$1.36M 0.06%
67,954
-114,951
-63% -$10.9M
TDOC icon
139
Teladoc Health
TDOC
$1.22B
$1.33M 0.06%
29,542
-338,935
-92% -$3.95M
TMO icon
140
Thermo Fisher Scientific
TMO
$209B
$1.13M 0.05%
18,688
-145,458
-89% -$21.5M
ATYR
141
aTyr Pharma
ATYR
$51.9M
$967K 0.04%
24,839
-5,529
-18% -$257K
CVBF icon
142
CVB Financial
CVBF
$4.07B
$920K 0.04%
191,210
-448,499
-70% -$7.6M
MAR icon
143
Marriott International
MAR
$90B
$896K 0.04%
6,374
-174,186
-96% -$11.7M
GILD icon
144
Gilead Sciences
GILD
$168B
$881K 0.04%
11,154
-399,621
-97% -$35.5M
EXAM
145
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
$873K 0.04%
14,950
-135,839
-90% -$4.63M
DIS icon
146
Walt Disney
DIS
$170B
$806K 0.03%
162,528
-253,582
-61% -$25.4M
B
147
DELISTED
Barnes Group Inc.
B
$780K 0.03%
11,482
-258,461
-96% -$8.79M
SNDX icon
148
Syndax Pharmaceuticals
SNDX
$1.69B
$760K 0.03%
8,612
-280,138
-97% -$3.84M
AX icon
149
Axos Financial
AX
$5.96B
$745K 0.03%
315,754
+32,133
+11% +$603K
BLKB icon
150
Blackbaud
BLKB
$2.07B
$743K 0.03%
11,213
-6,924
-38% -$437K

Similar funds

Tiverton Asset Management's Q2 2016 Portfolio in Review

As of Q2 2016, Tiverton Asset Management held 159 positions worth $2.38B, down 19% from $2.94B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tiverton Asset Management deployed $1.18B of net new capital in Q2 2016, adding to 66 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Apple, an estimated $118M trimmed.

  • Tiverton Asset Management added most to Intuitive Surgical in Q2 2016, an estimated $1.17B increase.
  • Tiverton Asset Management's biggest Q2 2016 reduction was Apple, cutting an estimated $118M.
  • Tiverton Asset Management fully exited Allergan plc in Q2 2016, selling an estimated $22.3M.
  • Tiverton Asset Management's ten largest holdings make up 27% of its $2.38B portfolio in Q2 2016.
  • Tiverton Asset Management opened 0 new positions and closed 6 in Q2 2016.
  • Tiverton Asset Management's portfolio value fell 19% quarter-over-quarter to $2.38B.

Based on Tiverton Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.